BOT (ASX) Ann: Botanix Announces Top Line BTX 1204 Atopic Dermatitis Data

Originally posted by Silent-Bubbles: ↑

Anything ' Non COVID-19 ' is simply superfluous to the main Pharmaceutical Game at the present moment , and hence a massive ' Flight to Quality ' being undertaken not just in this Industry but others right across the board as well.

I suppose you can take some comforts in the fact that having COH as at 31 December of $27.164 million together with trade and other receivables of another $7.80 million for a total of $34.964 million. On top of this you received in January a further R&D Tax Incentive refund of A$7,560,856 forthe 2018 / 2019 financial year which would then bring the total available Cash on Hand to some $42.5 million . And all this against current liabilities of only $2.035 million and estimated expenses represented largely by Research and Development expenses of $8.380 ( approx 57.2 % ). So it would not be unreasonable to expect a static or similar COH figure as at 31st March 2020.

So quite a strong position to be in while you wait this crisis out or re-direct some of your resources and / or testing capabilities into any possible COVID-19 solution processes and or discoveries. I particularly like the recent announcement where they spoke of the ineffectiveness in some cases of Nasal Bactroban ( mupirocin ) used in the pre-surgical environments. And this may become an even more important feature in our overall Health Systems.

There should also be some comfort taken by the Biotech Industry from the Governments Announcement announcement today of the creation of a Commission compiled from a vast range of Private Sector Industry Experts - none the least being David Thodey who as you ALL would know as the Chairman of the Board of CSIRO.

So IMO , after watching BOT very closely by the sidelines for sometime now , I have now entered with a position on the basis of my view of this recent drop being perhaps one of the more exceptional and unique buying opportunities.......

The COVID-19 Coordination Commission will include eminent Australians from the private and public sector, and be chaired by Nev Power, the former chief executive of Fortescue, with David Thodey to be deputy chairman.

Already on the board is former Labor MP Greg Combet, Jane Halton, the former head of the Finance Department, Paul Little the head of Toll, Catherine Tanna of Energy Australia, Phil Gaetjens the Secretary of the Department of Prime Minister and Cabinet, and Secretary of the Home Affairs Department Mike Pezzullo.

Mr Power said his role is going to be looking for opportunities to join businesses together to solve problems.
"Where there is a workforce that is no longer gainfully employed and where there is a workforce that's needed. Where there's equipment that can be re-deployed. Where we need to intervene to protect our critical supply chains and our utilities, and also, very importantly, looking to the future because we know that this virus will come and go," he said.

Expand

Well Said SB- welcome back into our game..for one last roll of the dice..

We are either going to celebrate after the Anti-micro game ( which i think they should purely focus on now) or go down in flames...

No.	Vol.	Price($)
11	410003	34.5¢

No.

Vol.

Price($)

410003

34.5¢

Price($)	Vol.	No.
35.0¢	346713	8

Price($)

Vol.

No.

35.0¢

346713

No.	Vol.	Price($)
11	410003	0.345
21	1198939	0.340
12	887560	0.335
29	2479852	0.330
5	853843	0.325

No.

Vol.

Price($)

410003

0.345

1198939

0.340

887560

0.335

2479852

0.330

853843

0.325

Price($)	Vol.	No.
0.350	346713	8
0.355	76367	5
0.360	381578	10
0.365	522058	4
0.370	327527	8

Price($)

Vol.

No.

0.350

346713

0.355

76367

0.360

381578

0.365

522058

0.370

327527

(20min delay)
Last 34.5¢		Change -0.020(5.48%)		Mkt cap ! $543.4M

Open	High	Low	Value	Volume
35.5¢	35.5¢	34.0¢	$4.566M	13.13M

Ann: Botanix Announces Top Line BTX 1204 Atopic Dermatitis Data, page-126

Ava Risk Group expands US presence with A$0.7M Substation Deal

Microcap Wrap: 5 explorers with news out today

Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom

Silver Mines models five new calderas close to 396Moz Bowdens deposit

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker

Lithium Universe (ASX:LU7) board visits Quebec to engage key stakeholders

Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%

ChemX Materials kicks off first stage works at WA high purity alumina pilot

Recce's R327 found effective against E.coli during clinical trial

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Botanix Announces Top Line BTX 1204 Atopic Dermatitis Data, page-126

Top Stories

Ava Risk Group expands US presence with A$0.7M Substation Deal

Microcap Wrap: 5 explorers with news out today

Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom

Silver Mines models five new calderas close to 396Moz Bowdens deposit

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker

Lithium Universe (ASX:LU7) board visits Quebec to engage key stakeholders

Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%

ChemX Materials kicks off first stage works at WA high purity alumina pilot

Recce's R327 found effective against E.coli during clinical trial

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News